Neuronasal

Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our 1st products are for concussion and are safe, repurposed drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded May 2014
  • Employees 0
  • Incorporation Type LLC
  • Website synaptic.bio

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free